EP2967406A1 - Method and system to calculate qeeg - Google Patents
Method and system to calculate qeegInfo
- Publication number
- EP2967406A1 EP2967406A1 EP14772675.6A EP14772675A EP2967406A1 EP 2967406 A1 EP2967406 A1 EP 2967406A1 EP 14772675 A EP14772675 A EP 14772675A EP 2967406 A1 EP2967406 A1 EP 2967406A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- eeg
- artifact
- quantitative
- electrodes
- recording
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 238000000034 method Methods 0.000 title claims abstract description 26
- 230000009467 reduction Effects 0.000 claims abstract description 7
- 238000012545 processing Methods 0.000 claims description 11
- 210000003205 muscle Anatomy 0.000 claims description 9
- 238000013528 artificial neural network Methods 0.000 claims description 7
- 238000001514 detection method Methods 0.000 claims description 6
- 230000008569 process Effects 0.000 claims description 4
- 230000001055 chewing effect Effects 0.000 claims description 3
- 230000000193 eyeblink Effects 0.000 claims description 3
- 230000000694 effects Effects 0.000 description 23
- 206010010904 Convulsion Diseases 0.000 description 15
- 210000004556 brain Anatomy 0.000 description 15
- 208000006011 Stroke Diseases 0.000 description 12
- 210000003128 head Anatomy 0.000 description 10
- 230000007177 brain activity Effects 0.000 description 6
- 230000004424 eye movement Effects 0.000 description 6
- 210000004761 scalp Anatomy 0.000 description 6
- 230000002490 cerebral effect Effects 0.000 description 5
- 238000012544 monitoring process Methods 0.000 description 5
- 238000003745 diagnosis Methods 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 210000002569 neuron Anatomy 0.000 description 4
- 230000002123 temporal effect Effects 0.000 description 4
- 206010015037 epilepsy Diseases 0.000 description 3
- 230000001787 epileptiform Effects 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 230000001052 transient effect Effects 0.000 description 3
- 230000005856 abnormality Effects 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 238000012880 independent component analysis Methods 0.000 description 2
- 230000004807 localization Effects 0.000 description 2
- 230000001537 neural effect Effects 0.000 description 2
- 230000001936 parietal effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 206010010071 Coma Diseases 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 208000003078 Generalized Epilepsy Diseases 0.000 description 1
- 206010061334 Partial seizures Diseases 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 229910021607 Silver chloride Inorganic materials 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 229910052770 Uranium Inorganic materials 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 238000010219 correlation analysis Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 239000002003 electrode paste Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 201000001993 idiopathic generalized epilepsy Diseases 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000007659 motor function Effects 0.000 description 1
- 230000036385 rapid eye movement (rem) sleep Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 1
- 230000007958 sleep Effects 0.000 description 1
- 208000019116 sleep disease Diseases 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- 210000003478 temporal lobe Anatomy 0.000 description 1
- 239000011135 tin Substances 0.000 description 1
- 229910052718 tin Inorganic materials 0.000 description 1
- 230000002618 waking effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7203—Signal processing specially adapted for physiological signals or for diagnostic purposes for noise prevention, reduction or removal
- A61B5/7207—Signal processing specially adapted for physiological signals or for diagnostic purposes for noise prevention, reduction or removal of noise induced by motion artifacts
- A61B5/7214—Signal processing specially adapted for physiological signals or for diagnostic purposes for noise prevention, reduction or removal of noise induced by motion artifacts using signal cancellation, e.g. based on input of two identical physiological sensors spaced apart, or based on two signals derived from the same sensor, for different optical wavelengths
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/25—Bioelectric electrodes therefor
- A61B5/279—Bioelectric electrodes therefor specially adapted for particular uses
- A61B5/291—Bioelectric electrodes therefor specially adapted for particular uses for electroencephalography [EEG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/316—Modalities, i.e. specific diagnostic methods
- A61B5/369—Electroencephalography [EEG]
- A61B5/372—Analysis of electroencephalograms
- A61B5/374—Detecting the frequency distribution of signals, e.g. detecting delta, theta, alpha, beta or gamma waves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7271—Specific aspects of physiological measurement analysis
- A61B5/7282—Event detection, e.g. detecting unique waveforms indicative of a medical condition
Definitions
- the present invention generally relates to a method and system for calculating a quantitative EEG.
- An electroencephalogram is a diagnostic tool that measures and records the electrical activity of a person's brain in order to evaluate cerebral functions.
- Multiple electrodes are attached to a person's head and connected to a machine by wires.
- the machine amplifies the signals and records the electrical activity of a person's brain.
- the electrical activity is produced by the summation of neural activity across a plurality of neurons. These neurons generate small electric voltage fields. The aggregate of these electric voltage fields create an electrical reading which electrodes on the person's head are able to detect and record.
- An EEG is a superposition of multiple simpler signals.
- the amplitude of an EEG signal typically ranges from 1 micro-Volt to 100 micro-Volts, and the EEG signal is approximately 10 to 20 milli-Volts when measured with subdural electrodes.
- the monitoring of the amplitude and temporal dynamics of the electrical signals provides information about the underlying neural activity and medical conditions of the person.
- An EEG is performed to: diagnose epilepsy; verify problems with loss of consciousness or dementia; verify brain activity for a person in a coma; study sleep disorders, monitor brain activity during surgery, and additional physical problems.
- positions for at least 70 are attached to a person's head during an EEG.
- the electrodes are referenced by the position of the electrode in relation to a lobe or area of a person's brain.
- An electrocardiogram (“EKG”) may also appear on an EEG display.
- the EEG records brain waves from different amplifiers using various combinations of electrodes called montages.
- Montages are generally created to provide a clear picture of the spatial distribution of the EEG across the cortex.
- a montage is an electrical map obtained from a spatial array of recording electrodes and preferably refers to a particular combination of electrodes examined at a particular point in time.
- bipolar montages consecutive pairs of electrodes are linked by connecting the electrode input 2 of one channel to input 1 of the subsequent channel, so that adjacent channels have one electrode in common.
- the bipolar chains of electrodes may be connected going from front to back (longitudinal) or from left to right (transverse).
- a bipolar montage signals between two active electrode sites are compared resulting in the difference in activity recorded.
- Another type of montage is the referential montage or monopolar montage.
- various electrodes are connected to input 1 of each amplifier and a reference electrode is connected to input 2 of each amplifier.
- a reference montage signals are collected at an active electrode site and compared to a common reference electrode.
- epileptiform abnormalities or “epilepsy waves.”
- epilepsy waves include spikes, sharp waves, and spike-and-wave discharges.
- Primary generalized epilepsy is suggested by spike- and-wave discharges that are widely spread over both hemispheres of the brain, especially if they begin in both hemispheres at the same time.
- Alpha waves have a frequency of 8 to 12 Hertz ("Hz"). Alpha waves are normally found when a person is relaxed or in a waking state when a person's eyes are closed but the person is mentally alert. Alpha waves cease when a person's eyes are open or the person is concentrating. Beta waves have a frequency of 13Hz to 30Hz. Beta waves are normally found when a person is alert, thinking, agitated, or has taken high doses of certain medicines. Delta waves have a frequency of less than 3Hz. Delta waves are normally found only when a person is asleep (non-REM or dreamless sleep) or the person is a young child.
- Theta waves have a frequency of 4Hz to 7Hz.
- Theta waves are normally found only when the person is asleep (dream or REM sleep) or the person is a young child.
- Gamma waves have a frequency of 30Hz to 100Hz.
- Gamma waves are normally found during higher mental activity and motor functions.
- Amplitude refers to the vertical distance measured from the trough to the maximal peak (negative or positive). It expresses information about the size of the neuron population and its activation synchrony during the component generation.
- Analogue to digital conversion refers to when an analogue signal is converted into a digital signal which can then be stored in a computer for further processing.
- Analogue signals are "real world" signals (e.g., physiological signals such as electroencephalogram, electrocardiogram or electrooculogram). In order for them to be stored and manipulated by a computer, these signals must be converted into a discrete digital form the computer can understand.
- Articles are electrical signals detected along the scalp by an EEG, but that originate from non-cerebral origin. There are patient related artifacts (e.g., movement, sweating, ECG, eye movements) and technical artifacts (50/60 Hz artifact, cable movements, electrode paste-related).
- patient related artifacts e.g., movement, sweating, ECG, eye movements
- technical artifacts 50/60 Hz artifact, cable movements, electrode paste-related
- electrophysiological equipment It magnifies the difference between two inputs (one amplifier per pair of electrodes).
- Electrode refers to a conductor used to establish electrical contact with a nonmetallic part of a circuit.
- EEG electrodes are small metal discs usually made of stainless steel, tin, gold or silver covered with a silver chloride coating. They are placed on the scalp in special positions.
- Electrode gel acts as a malleable extension of the electrode, so that the movement of the electrodes leads is less likely to produce artifacts. The gel maximizes skin contact and allows for a low-resistance recording through the skin.
- electrode positioning (10/20 system) refers to the standardized placement of scalp electrodes for a classical EEG recording. The essence of this system is the distance in percentages of the 10/20 range between Nasion-Inion and fixed points. These points are marked as the Frontal pole (Fp), Central (C), Parietal (P), occipital (O), and Temporal (T).
- the midline electrodes are marked with a subscript z, which stands for zero. The odd numbers are used as subscript for points over the left hemisphere, and even numbers over the right
- Electroencephalogram or “EEG” refers to the tracing of brain waves, by recording the electrical activity of the brain from the scalp, made by an electroencephalograph.
- Electroencephalograph refers to an apparatus for detecting
- brain waves also called encephalograph
- Epileptiform refers to resembling that of epilepsy.
- Frtering refers to a process that removes unwanted frequencies from a signal.
- Frters are devices that alter the frequency composition of the signal.
- “Montage” means the placement of the electrodes.
- the EEG can be monitored with either a bipolar montage or a referential one.
- Bipolar means that there are two electrodes per one channel, so there is a reference electrode for each channel.
- the referential montage means that there is a common reference electrode for all the channels.
- Morphology refers to the shape of the waveform.
- the shape of a wave or an EEG pattern is determined by the frequencies that combine to make up the waveform and by their phase and voltage relationships. Wave patterns can be described as being: "Monomorphic”. Distinct EEG activity appearing to be composed of one dominant activity. "Polymorphic”, distinct EEG activity composed of multiple frequencies that combine to form a complex waveform. "Sinusoidal”. Waves resembling sine waves. Monomorphic activity usually is sinusoidal. "Transient”. An isolated wave or pattern that is distinctly different from background activity.
- Spike refers to a transient with a pointed peak and a duration from 20 to under 70 msec.
- sharp wave refers to a transient with a pointed peak and duration of 70-200 msec.
- neural network algorithms refers to algorithms that identify sharp transients that have a high probability of being epileptiform
- Periodity refers to the distribution of patterns or elements in time
- the activity may be generalized, focal or lateralized.
- An EEG epoch is an amplitude of a EEG signal as a function of time and frequency.
- Quantitative EEG was been used for some time in the analysis of EEG. The most common use is for time compressed graphical output using FFT. This type of graphical output can be interpreted by a human reader to show, for example an overview of a long period EEG in the frequency range.
- QEEG can also be used to produce time averaged results with a single numeric value at a given point in time. This could be as simple as an average amplitude. Or it could be a computation limited to waves in a single frequency range.
- QEEG can be limited to a subset of the number of recorded channels.
- the computation is reflective of activity in a hemisphere, or smaller portion of the brain.
- the computation might be computed as a relative value of two subsets of the channels or two different frequency ranges. The idea being that a change in these relative values could be diagnostically significant.
- One example is the diagnosis of stroke. It is believed that when a stroke begins that changes in brain activity are almost immediately reflected in an EEG. This will occur in many cases significantly before there are clinical symptoms. Therefore, there is great interest in continuous monitoring of patients at risk of stroke to provide early diagnosis and treatment.
- the solution is to computationally remove many of the artifacts present in a record prior to QEEG processing. In this way the signal to noise ratio can be dramatically improved, and the resulting QEEG computation will reflect cerebral activity. At this point it is then possible to both determine what types of QEEG will be effective in diagnosis, and to use it clinically.
- a physician could begin continuous monitoring of one or more QEEg parameters that have been determined to be diagnostic. Having established a baseline the physician could set ranges for these parameters and if the QEEG moved outside these ranges the staff would be alerted to a possible stroke.
- a system might determine the baseline and set ranges automatically, or it might use an intelligent system such as neural networks to determine the QEEG to use, and a set of changes that represent a stroke.
- a stroke is only a single example, and many other conditions affecting cerebral activity can diagnosed in this manner.
- FIG. 1 is an image of a quantitative EEG.
- FIG. 2 is a diagram of a system for calculating a quantitative EEG.
- FIG. 3 is a map for electrode placement for an EEG.
- FIG. 4 is a detailed map for electrode placement for an EEG.
- FIG. 5 is an illustration of a CZ reference montage.
- FIG. 6 is an illustration of an EEG recording containing a seizure, a muscle artifact and an eye movement artifact.
- FIG. 7 is an illustration of the EEG recording of FIG. 6 with the
- FIG. 8 is an illustration of the EEG recording of FIG. 7 with the eye movement artifact removed.
- FIG. 9 is a flow chart for a method for calculating a quantitative EEG.
- FIG. 10 is a flow chart method for calculating a quantitative EEG.
- FIG. 1 1 is a diagram of a system for calculating a quantitative EEG.
- FIG. 1 An image 100 of a quantitative EEG (“qEEG”) is shown in FIG. 1.
- the method and system allows for a qEEG to be generated from an artifact reduced EEG recording without having to remove portions of the EEG recording to prevent artifacts from influencing the qEEG.
- FIG. 2 illustrates a system 20 for calculating a quantitative EEG.
- a patient 15 wears an electrode cap 31, consisting of a plurality of electrodes 35a-35c, attached to the patient's head with wires 38 from the electrodes 35 connected to an EEG machine component 40 which consists of an amplifier 42 for amplifying the signal to a computer 41 with a processor, which is used to analyze the signals from the electrodes 35 and generate an EEG recording 51 and a qEEG, which can be viewed on a display 50.
- an electrode utilized with the present invention is detailed in Wilson et al. , U. S .
- Patent Number 8112141 for a Method And Device For Quick Press On EEG Electrode which is hereby incorporated by reference in its entirety.
- the EEG is optimized for automated artifact filtering.
- the EEG recordings are then processed using neural network algorithms to generate a processed EEG recording which is used to generate a qEEG.
- a patient has a plurality of electrodes attached to the patient's head with wires from the electrodes connected to an amplifier for amplifying the signal to a processor, which is used to analyze the signals from the electrodes and create an EEG recording.
- the brain produces different signals at different points on a patient's head.
- Multiple electrodes are positioned on a patient's head as shown in FIGS. 3 and 4.
- the CZ site is in the center.
- Fpl on FIG. 4 is represented in channel FP1-F3 on FIG. 6.
- the number of electrodes determines the number of channels for an EEG. A greater number of channels produce a more detailed representation of a patient's brain activity.
- each amplifier 42 of an EEG machine component 40 corresponds to two electrodes 35 attached to a head of the patient 15.
- the output from an EEG machine component 40 is the difference in electrical activity detected by the two electrodes.
- the placement of each electrode is critical for an EEG report since the closer the electrode pairs are to each other, the less difference in the brainwaves that are recorded by the EEG machine component 40.
- the EEG is optimized for automated artifact filtering.
- the EEG is optimized for automated artifact filtering.
- a processing engine performs continuous analysis of the EEG waveforms and determines the presence of most types of electrode artifact on a channel-by-channel basis. Much like a human reader, the processing engine detects artifacts by analyzing multiple features of the EEG traces. The preferred artifact detection is independent of impedance checking.
- the processing monitors the incoming channels looking for electrode artifacts. When artifacts are detected they are automatically removed from the seizure detection process and optionally removed from the trending display. This results in much a much higher level of seizure detection accuracy and easier to read trends than in previous generation products.
- BSS Blind Source Separation
- CCA canonical correlation analysis
- ICA Independent Component Analysis
- an algorithm called BSS-CCA is used to remove the effects of muscle activity from the EEG.
- the algorithm on the recorded montage will frequently not produce optimal results. In this case it is generally optimal to use a montage where the reference electrode is one of the vertex electrodes such as CZ in the international 10-20 standard.
- the recorded montage would first be transformed into a CZ reference montage prior to artifact removal. In the event that the signal at CZ indicates that it is not the best choice then the algorithm would go down a list of possible reference electrodes in order to find one that is suitable.
- FIGS. 5-8 illustrate how removing artifacts from the EEG signal allow for a clearer illustration of a brain's true activity for the reader.
- FIG. 6 is an illustration of an EEG recording 4000 containing a seizure, a muscle artifact and an eye movement artifact.
- FIG. 7 is an illustration of the EEG recording 5000 of FIG. 6 with the muscle artifact removed.
- FIG. 8 is an illustration of the EEG recording 6000 of FIG. 7 with the eye movement artifact removed.
- a seizure probability trend a rhythmicity spectrogram, left hemisphere trend, a rhythmicity spectrogram, right hemisphere trend, a FFT spectrogram left hemisphere trend, a FFT spectrogram right hemisphere trend, an asymmetry relative spectrogram trend, an asymmetry absolute index trend, an aEEG trend, and a suppression ration, left hemisphere and right hemisphere trend.
- Rhythmicity spectrograms allow one to see the evolution of seizures in a single image.
- the rhythmicity spectrogram measures the amount of rhythmicity which is present at each frequency in an EEG record.
- the seizure probability trend shows a calculated probability of seizure activity over time.
- the seizure probability trend shows the duration of detected seizures, and also suggests areas of the record that may fall below the seizure detection cutoff, but are still of interest for review.
- the seizure probability trend when displayed along with other trends, provides a comprehensive view of quantitative changes in an EEG.
- a method for calculating a quantitative EEG is generally designated 600.
- EEG signals are generated from an EEG machine comprising a plurality of electrodes, an amplifier and processor.
- the EEG signals are processed continuously for artifact reduction to generate a processed EEG recording.
- a quantitative EEG is calculated from the processed EEG recording.
- Fast Fourier Transform signal processing is used to compute the quantitative EEG.
- the reduced artifact types are selected from the group comprising an eye blink artifact, a muscle artifact, a tongue movement artifact, a chewing artifact, and a heartbeat artifact.
- method for calculating a quantitative EEG is generally designated 700.
- EEG signals are generated from an EEG machine comprising electrodes, an amplifier and processor.
- the EEG signals are processed continuously for artifact reduction to generate a continuous artifact reduced EEG data.
- a quantitative EEG is computed using continuous artifact reduced EEG data in near real time.
- the method further includes anticipating a stroke based on the quantitative EEG.
- the method alternatively includes utilizing the quantitative EEG for seizure detection.
- FIGS. 11 and 12 illustrate a system for calculating a quantitative EEG.
- a patient 15 wears an electrode cap 31, consisting of a plurality of electrodes 35a-35c, attached to the patient's head with wires 38 from the electrodes 35 connected to an EEG machine component 40 which consists of an amplifier 42 for amplifying the signal to a computer 41 with a processor, which is used to analyze the signals from the electrodes 35 and generate an EEG recording and a qEEG 51, which can be viewed on a display 50.
- the CPU 41 includes a software program for a neural network algorithm and a software program for a qEEG engine. AS shown in FIG.
- an artifact reduction engine a qEEG engine 47, a microprocessor 44, a memory 42, a memory controller 43 and an I/O 48 ar components of the EEEG machine 40.
- the EEG is optimized for automated artifact filtering.
- the EEG recordings are then processed using neural network algorithms to generate a processed EEG recording which is analyzed for display.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Signal Processing (AREA)
- Psychiatry (AREA)
- Artificial Intelligence (AREA)
- Physiology (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Psychology (AREA)
- Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/830,742 US20140194768A1 (en) | 2011-09-19 | 2013-03-14 | Method And System To Calculate qEEG |
PCT/US2014/020933 WO2014158921A1 (en) | 2013-03-14 | 2014-03-05 | Method and system to calculate qeeg |
Publications (2)
Publication Number | Publication Date |
---|---|
EP2967406A1 true EP2967406A1 (en) | 2016-01-20 |
EP2967406A4 EP2967406A4 (en) | 2016-10-26 |
Family
ID=51625085
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP14772675.6A Ceased EP2967406A4 (en) | 2013-03-14 | 2014-03-05 | Method and system to calculate qeeg |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP2967406A4 (en) |
JP (1) | JP6612733B2 (en) |
CN (1) | CN105188525A (en) |
WO (1) | WO2014158921A1 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3419520A4 (en) * | 2016-02-22 | 2019-10-16 | Persyst Development Corporation | Impedance monitoring for quantitative eeg |
FR3061850B1 (en) * | 2017-01-19 | 2023-02-10 | Bioserenity | DEVICE FOR MONITORING THE ELECTRO-PHYSIOLOGICAL ACTIVITY OF A SUBJECT |
US10555670B2 (en) * | 2017-07-10 | 2020-02-11 | International Business Machines Corporation | Adaptive filtration of sweat artifacts during electronic brain monitoring |
KR102514479B1 (en) * | 2020-12-10 | 2023-03-27 | 주식회사 브레인유 | Method for providing information of epilepsy and device using the same |
KR20230173439A (en) * | 2022-06-17 | 2023-12-27 | 연세대학교 산학협력단 | Methods for predicting delirium occurrence and devices using the same |
JP7455315B1 (en) | 2022-10-11 | 2024-03-26 | 株式会社JiMED | Program, manufacturing method, manufacturing equipment and connection method |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5230346A (en) * | 1992-02-04 | 1993-07-27 | The Regents Of The University Of California | Diagnosing brain conditions by quantitative electroencephalography |
JPH08117200A (en) * | 1994-10-24 | 1996-05-14 | Kitsusei Comtec Kk | Measuring instrument and its display |
JP3523007B2 (en) * | 1997-03-25 | 2004-04-26 | 中沢 弘 | Satisfaction measurement system and feedback device |
JP3160621B2 (en) * | 1998-05-21 | 2001-04-25 | 京都大学長 | EEG measurement device |
JP2000279387A (en) * | 1999-03-31 | 2000-10-10 | Nec Medical Systems Kk | Brain wave topography display method and brain wave waveform monitor device |
US6594524B2 (en) * | 2000-12-12 | 2003-07-15 | The Trustees Of The University Of Pennsylvania | Adaptive method and apparatus for forecasting and controlling neurological disturbances under a multi-level control |
WO2002064024A2 (en) * | 2001-02-13 | 2002-08-22 | Jordan Neuroscience, Inc. | Automated realtime interpretation of brain waves |
US7672717B1 (en) * | 2003-10-22 | 2010-03-02 | Bionova Technologies Inc. | Method and system for the denoising of large-amplitude artifacts in electrograms using time-frequency transforms |
WO2005117693A1 (en) * | 2004-05-27 | 2005-12-15 | Children's Medical Center Corporation | Patient-specific seizure onset detection system |
JP2006192105A (en) * | 2005-01-14 | 2006-07-27 | Nippon Koden Corp | Biological information display system |
RU2007135627A (en) * | 2005-03-04 | 2009-04-10 | Ментис Кура Ехф. (Is) | METHOD AND SYSTEM FOR EVALUATING NEUROLOGICAL CONDITIONS |
US7904144B2 (en) * | 2005-08-02 | 2011-03-08 | Brainscope Company, Inc. | Method for assessing brain function and portable automatic brain function assessment apparatus |
BRPI0817035A2 (en) * | 2007-08-23 | 2019-02-26 | Massacfhusetts Institut Of Tech | method and instrument for reducing the number of channels in an epileptic seizure detector based on electroencephalography |
WO2009081343A1 (en) * | 2007-12-20 | 2009-07-02 | Koninklijke Philips Electronics N.V. | Electrode diversity for body-coupled communication systems |
JP5266597B2 (en) * | 2008-06-17 | 2013-08-21 | 株式会社国際電気通信基礎技術研究所 | Brain activity information output device, brain activity information output method |
JP5167368B2 (en) * | 2008-10-29 | 2013-03-21 | トヨタ自動車株式会社 | MOBILE BODY CONTROL DEVICE AND MOBILE BODY CONTROL METHOD |
US8838226B2 (en) * | 2009-12-01 | 2014-09-16 | Neuro Wave Systems Inc | Multi-channel brain or cortical activity monitoring and method |
WO2011088227A1 (en) * | 2010-01-13 | 2011-07-21 | Regents Of The University Of Minnesota | Imaging epilepsy sources from electrophysiological measurements |
RU110632U1 (en) * | 2011-06-28 | 2011-11-27 | Андрей Борисович Степанов | AUTOMATED ELECTROENCEPHALOGRAM ANALYSIS SYSTEM |
-
2014
- 2014-03-05 CN CN201480015378.7A patent/CN105188525A/en active Pending
- 2014-03-05 WO PCT/US2014/020933 patent/WO2014158921A1/en active Application Filing
- 2014-03-05 JP JP2016500691A patent/JP6612733B2/en active Active
- 2014-03-05 EP EP14772675.6A patent/EP2967406A4/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
WO2014158921A1 (en) | 2014-10-02 |
JP6612733B2 (en) | 2019-11-27 |
JP2016514022A (en) | 2016-05-19 |
EP2967406A4 (en) | 2016-10-26 |
CN105188525A (en) | 2015-12-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8666484B2 (en) | Method and system for displaying EEG data | |
EP2922466B1 (en) | Method and system for displaying the amount of artifact present in an eeg recording | |
US20170188865A1 (en) | Method And System To Calculate qEEG | |
US10022091B2 (en) | User interface for artifact removal in an EEG | |
US20170172414A1 (en) | Multiple Patient EEG Monitoring | |
US11317871B2 (en) | Method and system for detecting and removing EEG artifacts | |
US8972001B2 (en) | Method and system for displaying data | |
EP2757941B1 (en) | System for analyzing an eeg recording | |
JP6612733B2 (en) | qEEG calculation method | |
JP2016514022A5 (en) | ||
EP3419520A1 (en) | Impedance monitoring for quantitative eeg | |
WO2013078469A1 (en) | Method and system for displaying eeg data and user interface | |
US20140012151A1 (en) | Method And System For Displaying EEG Data | |
EP2973347B1 (en) | Multiple patient eeg monitoring | |
US11219416B2 (en) | Graphically displaying evoked potentials | |
US20210369181A1 (en) | Method And System For Visualizing Data From Electrical Source Imaging | |
EP2782498B1 (en) | Method and system for displaying eeg data and user interface |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20151002 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
DAX | Request for extension of the european patent (deleted) | ||
A4 | Supplementary search report drawn up and despatched |
Effective date: 20160922 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61B 5/0476 20060101AFI20160916BHEP |
|
17Q | First examination report despatched |
Effective date: 20180405 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: PERSYST DEVELOPMENT CORPORATION |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R003 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED |
|
18R | Application refused |
Effective date: 20200512 |